What does Dr. Jan Berger - Dr. Sascha Van Nuijs do?

Dr. Jan Berger - Dr. Sascha Van Nuijs is a physiotherapy practice in Boechout. Private Limited, started on 7 June 2010, 1 establishment.

What is the address of Dr. Jan Berger - Dr. Sascha Van Nuijs?

The registered office of Dr. Jan Berger - Dr. Sascha Van Nuijs is located at Janssenlei 9, 2530 Boechout.

Is Dr. Jan Berger - Dr. Sascha Van Nuijs still active?

Yes. According to the CBE (17 September 2026) Dr. Jan Berger - Dr. Sascha Van Nuijs is active, legal situation “Normale toestand”, started on 7 June 2010.

Is Dr. Jan Berger - Dr. Sascha Van Nuijs registered on Peppol?

Yes, Dr. Jan Berger - Dr. Sascha Van Nuijs is registered on the Peppol network with ID 0208:0826563427.

What is the enterprise number of Dr. Jan Berger - Dr. Sascha Van Nuijs?

The enterprise number of Dr. Jan Berger - Dr. Sascha Van Nuijs is BE0826563427.

When was Dr. Jan Berger - Dr. Sascha Van Nuijs founded?

Dr. Jan Berger - Dr. Sascha Van Nuijs was founded on 7 June 2010.

Who are the directors of Dr. Jan Berger - Dr. Sascha Van Nuijs?

According to the 2025 annual accounts, the directors of Dr. Jan Berger - Dr. Sascha Van Nuijs are: Jan BERGER, Sascha VAN NUIJS.

Is Dr. Jan Berger - Dr. Sascha Van Nuijs a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 7 June 2010; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Dr. Jan Berger - Dr. Sascha Van Nuijs make in 2025?

Dr. Jan Berger - Dr. Sascha Van Nuijs posted a profit after taxes of € 269,146 in financial year 2025.

What is the revenue of Dr. Jan Berger - Dr. Sascha Van Nuijs?

As a small company, Dr. Jan Berger - Dr. Sascha Van Nuijs is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 353,292.

Dr. Jan Berger - Dr. Sascha Van Nuijs (Private Limited)

Dossier Dr. Jan Berger - Dr. Sascha Van Nuijs, printed on 17 September 2026 from databakkes.be/en/0826563427/dr-jan-berger-dr-sascha-van-nuijs. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Jan Berger - Dr. Sascha Van Nuijs from Boechout, company number BE0826563427, closed financial year 2025 with a result of € 269,146 after tax. For that financial year Dr. Jan Berger - Dr. Sascha Van Nuijs recorded a gross margin of € 353,292 and equity of € 1.6 million. Compared with financial year 2024, the result moved from € 337,093 to € 269,146. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Growing

€ 1.6 million

▲ 21% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 269,146

▼ 20% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 180,170

▼ 51% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 1.5 million.

People and assets in 2025

Vehicles and equipment

€ 10,956

▼ 35% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 108,052

▼ 17% vs 2024

€ 22,281 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 10,256

▲ 119% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 29,692

▲ 66% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 207,025 Gross margin 2022: € 207,025 First fiscal year in the series	€ 227,396 Gross margin 2023: € 227,396 ▲ 10% vs 2022 (€ 207,025) Favourable step	€ 518,461 Gross margin 2024: € 518,461 ▲ 128% vs 2023 (€ 227,396) Favourable step	€ 353,292 Gross margin 2025: € 353,292 ▼ 32% vs 2024 (€ 518,461) Unfavourable step	▼ 32%
Profit after taxes	€ 217,029 Profit after taxes 2022: € 217,029 First fiscal year in the series	€ 176,718 Profit after taxes 2023: € 176,718 ▼ 19% vs 2022 (€ 217,029) Unfavourable step	€ 337,093 Profit after taxes 2024: € 337,093 ▲ 91% vs 2023 (€ 176,718) Favourable step	€ 269,146 Profit after taxes 2025: € 269,146 ▼ 20% vs 2024 (€ 337,093) Unfavourable step	▼ 20%
Equity	€ 1,124,420 Equity 2022: € 1,124,420 First fiscal year in the series	€ 1,131,988 Equity 2023: € 1,131,988 ▲ 1% vs 2022 (€ 1,124,420) Favourable step	€ 1,281,081 Equity 2024: € 1,281,081 ▲ 13% vs 2023 (€ 1,131,988) Favourable step	€ 1,550,227 Equity 2025: € 1,550,227 ▲ 21% vs 2024 (€ 1,281,081) Favourable step	▲ 21%
Total debts	€ 178,271 Total debts 2022: € 178,271 First fiscal year in the series	€ 168,730 Total debts 2023: € 168,730 ▼ 5% vs 2022 (€ 178,271) Favourable step	€ 166,247 Total debts 2024: € 166,247 ▼ 1% vs 2023 (€ 168,730) Favourable step	€ 150,199 Total debts 2025: € 150,199 ▼ 10% vs 2024 (€ 166,247) Favourable step	▼ 10%
Cash	€ 58,279 Cash 2022: € 58,279 First fiscal year in the series	€ 142,314 Cash 2023: € 142,314 ▲ 144% vs 2022 (€ 58,279) Favourable step	€ 370,183 Cash 2024: € 370,183 ▲ 160% vs 2023 (€ 142,314) Favourable step	€ 180,170 Cash 2025: € 180,170 ▼ 51% vs 2024 (€ 370,183) Unfavourable step	▼ 51%
Retained profit	€ 1,118,220 Retained profit 2022: € 1,118,220 First fiscal year in the series	€ 1,125,788 Retained profit 2023: € 1,125,788 ▲ 1% vs 2022 (€ 1,118,220) Favourable step	€ 1,274,881 Retained profit 2024: € 1,274,881 ▲ 13% vs 2023 (€ 1,125,788) Favourable step	€ 1,544,027 Retained profit 2025: € 1,544,027 ▲ 21% vs 2024 (€ 1,274,881) Favourable step	▲ 21%
Dividend	€ 170,850 Dividend 2022: € 170,850 First fiscal year in the series	€ 169,150 Dividend 2023: € 169,150 ▼ 1% vs 2022 (€ 170,850) Unchanged	€ 188,000 Dividend 2024: € 188,000 ▲ 11% vs 2023 (€ 169,150) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 188,000) Unchanged	▼ 100%
Bank debt	€ 172,460 Bank debt 2022: € 172,460 First fiscal year in the series	€ 149,907 Bank debt 2023: € 149,907 ▼ 13% vs 2022 (€ 172,460) Favourable step	€ 129,418 Bank debt 2024: € 129,418 ▼ 14% vs 2023 (€ 149,907) Favourable step	€ 108,052 Bank debt 2025: € 108,052 ▼ 17% vs 2024 (€ 129,418) Favourable step	▼ 17%
Balance sheet total	€ 1,302,691 Balance sheet total 2022: € 1,302,691 First fiscal year in the series	€ 1,300,718 Balance sheet total 2023: € 1,300,718 Unchanged (€ 1,302,691) Unchanged	€ 1,447,328 Balance sheet total 2024: € 1,447,328 ▲ 11% vs 2023 (€ 1,300,718) Unchanged	€ 1,700,426 Balance sheet total 2025: € 1,700,426 ▲ 17% vs 2024 (€ 1,447,328) Unchanged	▲ 17%

Key figures of Dr. Jan Berger - Dr. Sascha Van Nuijs, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Jan Berger - Dr. Sascha Van Nuijs?

What happened at Dr. Jan Berger - Dr. Sascha Van Nuijs in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2030 Jan BERGER stepped down as director. NBB
2030 Sascha VAN NUIJS stepped down as director. NBB
Aug 31, 2026 New annual accounts for financial year 2025: profit of € 269,146 (▼ 20% vs 2024). filed late Source: NBB ↗
Jun 7, 2010 New establishment in Boechout. KBO
2010 Jan BERGER became a director. NBB
2010 Sascha VAN NUIJS became a director. NBB
Jun 7, 2010 Start of the company according to the CBE. KBO

In short

From € 217,029 profit in 2022 to € 269,146 profit in 2025.

Paid € 426,936 in corporate taxes since 2022.

Best year ever: 2024, with € 337,093 profit.

Paid out € 528,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Jan Berger - Dr. Sascha Van Nuijs? We notify you, reason included.

Follow Dr. Jan Berger - Dr. Sascha Van Nuijs

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Directors

According to the 2025 annual accounts

Jan BERGER

Director

Also active at: GEMA CONCEPT

since 2010 · until 2030

Sascha VAN NUIJS

Director

since 2010 · until 2030

Establishments

Establishment units

Physical locations of this company

Registered office

Janssenlei 9

2530 Boechout

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Celest

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0826.563.427

VAT number

BE 0826.563.427

Registered office

Janssenlei 9, 2530 Boechout

Names & denominations

Dr. Jan Berger - Dr. Sascha Van Nuijs

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

7 June 2010

Peppol

Active · Active since 26 Jul 2024

Activities · NACE

Activiteiten op het gebied van kinesitherapie

Ambulante revalidatieactiviteiten

View on CBE Public ↗ Annual accounts (NBB) ↗